Neurodiagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

For the diagnosis of neurological disorders, neurodiagnostic devices are used. Neurodiagnostics can be used to diagnose disorders such as stroke, migraine, epilepsy, Parkinson's disease, and stroke. Neurodiagnostics products include in-vitro diagnostics and diagnostic & imaging system. Diagnostic & imaging system includes devices such as , MRI scanner, CT scanner and PET scanner. Increasing prevalence of neurological disorders and neurodegenerative disorders along with technological advancements in neurodiagnostics are expected to drive market growth during the forecast period.

MARKET SCOPE

The "Global Neurodiagnostics Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the neurodiagnostics market with detailed market segmentation by product, indication and end user. The report provides key statistics on the market status of the leading neurodiagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on product the market is segmented as, diagnostic imaging systems, clinical diagnostic instruments, reagents and consumables.
  
•   Based on indication the market is segmented as, neurodegenerative diseases, epilepsy, stroke, headache disorders, and sleep disorders.
  
•   Based on end user the market is segmented as, hospitals and surgical centers, diagnostic laboratories and imaging centers, neurology centers, ambulatory care centers, research laboratories and academic institutes.
  

MARKET DYNAMICS
Drivers:

•   Increasing prevalence of neurological diseases & disorders is the key driver for the market growth.
  
•   Technological advancements in neurodiagnostic devices and new product launches.
  
•   Increasing number of hospitals and diagnostic centers.
  
•   Advancement in proteomics and genomics for the diagnosis of neurodegenerative diseases.
  

Restraints:

•   Whereas, high cost of neurodiagnostic devices and growth in adoption of refurbished devices are expected to hamper market growth during the forecast period.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The neurodiagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the neurodiagnostics market in these regions.

IMPACT OF COVID-19 ON NEURODIAGNOSTICS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Neurodiagnostics Market Report Analysis

Neurodiagnostics Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• General Electric Company
• Koninklijke Philips N.V.
• Siemens Healthcare GmbH
• Hitachi, Ltd.
• Canon Medical Systems, USA
• Natus Medical Incorporated
• NIHON KOHDEN CORPORATION
• Advanced Brain Monitoring, Inc.
• Lifelines Neuro Company, LLC

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Product

• Diagnostic Imaging Systems
• Clinical Diagnostic Instruments
• Reagents and Consumables

By Indication

• Neurodegenerative Diseases
• Epilepsy
• Stroke
• Headache Disorders
• Sleep Disorders

By End User

• Hospitals and Surgical Centers
• Diagnostic Laboratories and Imaging Centers
• Neurology Centers
• Ambulatory Care Centers
• Research Laboratories and Academic Institutes

MARKET PLAYERS

The report covers key developments in the neurodiagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from neurodiagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for neurodiagnostics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the neurodiagnostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   General Electric Company
  
•   Koninklijke Philips N.V.
  
•   Siemens Healthcare GmbH
  
•   Hitachi, Ltd.
  
•   Canon Medical Systems, USA
  
•   Natus Medical Incorporated
  
•   NIHON KOHDEN CORPORATION
  
•   Advanced Brain Monitoring, Inc.
  
•   Lifelines Neuro Company, LLC
  
•   Mitsar Co., Ltd.
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Neurodiagnostics Market Report Scope